This spatial enrichment of C1R in these microenvironments reflects the convergence of hypoxia‐driven and TGF‐β‐mediated pathways that collectively sustain aggressive mesenchymal phenotypes in GBM. The gene discussed is TGFB1; the disease is glioblastoma.